When Blood Clots Strike Young: What Every Doctor Should Know About VTE in Millennials – Unusual Thrombotic Presentations and Risk Factors Please like and subscribe if you enjoyed this video :-) Abstract Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT)
Cardiology
The Iron Truth: Are We Missing the Signs of Iron Overload? A Review of Hemochromatosis and Underdiagnosis in Practice
Anemia of Inflammation vs Iron Deficiency: New Diagnostic Tools and Therapies
How AI Achieves 94% Accuracy in Early Disease Detection: New Research Findings
Efficacy of Telemedicine in Improving Healthcare Access Across Specialties
Efficacy of Telemedicine in Improving Healthcare Access Across Specialties Please like and subscribe if you enjoyed this video :-) Abstract This paper examines the effectiveness of telemedicine in improving access to healthcare across various medical specialties. By analyzing recent evidence from diverse
SGLT2 Inhibitors in Heart Failure: New Evidence Changes Treatment Protocols
Heart Ablation Success Rate: New Study Shows 87% Long-Term Freedom from AF
Heart Ablation Success Rate: New Study Shows 87% Long-Term Freedom from AF Introduction Recent advancements in heart ablation have led to remarkable improvements in success rates, particularly with the use of AI-guided procedures. Studies show that AI-assisted ablation achieves an 88% success rate in keeping patients free from atrial
Breakthrough Heart Treatments of 2025- A New Era in Cardiology
IRON DEFICIENCY’S IMPACT ON NEW-ONSET CHRONIC HEART FAILURE OUTCOME: DANISH HEART FAILURE REGISTRY INSIGHTS
Dofetilide In Structural Heart Disease
Dofetilide In Structural Heart Disease Overview Dofetilide, a class III antiarrhythmic drug, is approved for managing atrial fibrillation and atrial flutter, but it has also been used off-label to treat premature ventricular complexes (PVCs) and ventricular tachycardias (VTs). This study aimed to assess the efficacy and safety of dofetilide for